Division of Cardiovascular and Diabetes Research, The LIGHT Laboratories, University of Leeds, Leeds, UK.
Blood. 2010 Apr 1;115(13):2674-81. doi: 10.1182/blood-2009-08-231316. Epub 2010 Jan 19.
Factor XIII-A (FXIII-A) is present in the cytosol of platelets, megakaryocytes, monocytes, osteoblasts, and macrophages and may be released from cells by a nonclassical pathway. We observed that plasma FXIII-A levels were unchanged in thrombocytopenic mice (Bcl-x(Plt20/Plt20) and Mpl(-/-)), which implicates nonclassical secretion from nucleated cells as the source of plasma FXIII-A. We, therefore, examined the intracellular targeting of FXIII-A in the THP-1 (monocyte/macrophage) cell line and in human monocyte-derived macrophages. Metabolic labeling of THP-1 cells did not show release of (35)S-FXIII-A either under basal conditions or when interleukin 1-beta was released in response to cell stress. However, immunofluorescence of THP-1 cells and primary macrophages showed that FXIII-A associated with podosomes and other structures adjacent to the plasma membrane, which also contain trans-Golgi network protein-46 and Golgi matrix protein-130 (GM130) but not the endoplasmic reticulum luminal protein, protein disulphide isomerase. Further, FXIII-A was present in GM130-positive intracellular vesicles that could mediate its transport, and in other contexts GM130 and its binding partner GRASP have been implicated in the delivery of nonclassically secreted proteins to the plasma membrane. Hence, this mechanism may precede FXIII-A release into the extracellular matrix from macrophages and its release into plasma from the cell type of origin.
凝血因子 XIII-A(FXIII-A)存在于血小板、巨核细胞、单核细胞、成骨细胞和巨噬细胞的细胞质中,并且可能通过非经典途径从细胞中释放。我们观察到血小板减少症小鼠(Bcl-x(Plt20/Plt20)和 Mpl(-/-))的血浆 FXIII-A 水平没有变化,这表明核细胞的非经典分泌是血浆 FXIII-A 的来源。因此,我们研究了 THP-1(单核细胞/巨噬细胞)细胞系和人单核细胞衍生的巨噬细胞中 FXIII-A 的细胞内靶向。THP-1 细胞的代谢标记在基础条件下或细胞应激时白细胞介素 1-β释放时均未显示出(35)S-FXIII-A 的释放。然而,THP-1 细胞和原代巨噬细胞的免疫荧光显示,FXIII-A 与足突和靠近质膜的其他结构相关,这些结构还包含跨高尔基网络蛋白-46 和高尔基基质蛋白-130(GM130),但不包含内质网腔蛋白,蛋白二硫键异构酶。此外,FXIII-A 存在于 GM130 阳性的细胞内囊泡中,这些囊泡可能介导其运输,并且在其他情况下,GM130 及其结合伴侣 GRASP 已被牵连到非经典分泌蛋白到质膜的输送中。因此,这种机制可能先于巨噬细胞将 FXIII-A 释放到细胞外基质中,以及细胞起源类型将其释放到血浆中。